alexa Can Tau Pathobiology Be Phenocopied In A Cellular Expression Model?

Journal of Neuroscience and Neuropharmacology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Recommended Journals

Share This Page

Additional Info

Loading Please wait..

7th Global Experts Meeting on NEUROPHARMACOLOGY
July 31-August 02, 2017 | Milan, Italy

Joel B Schachter, Xufan Tian, Mali Cosden, John Majercak, Fred Hess, John J Renger and Chris J Winrow
Merck Research Laboratories, USA
ScientificTracks Abstracts: Neurochem Neuropharm
DOI: 10.4172/2469-9780-C1-005
Tau hyperphosphorylation and formation of insoluble tau deposits are principal aspects of the neurofibrillary pathology associated with Alzheimer’s disease (AD) and other neurodegenerative tauopathies. Despite a histology-based focus on insoluble filamentous tau pathology, small soluble tau oligomers have recently been implicated in the promotion of neurodegenerative activities and are now widely viewed as central participants in disease-related neurodegeneration. The factors that initiate the aberrant post-translational processing of tau and the generation of toxic tau oligomers are not well defined, but hyperphosphorylation has been implicated to play a critical role in tau aggregation. We have generated a cellular model in which full length human tau is expressed as a dimerlike structure that we refer to as tandem repeat tau (TRT). Cellular expression of TRT results in rapid hyperphosphorylation of the protein at disease-relevant epitopes. The rapid hyperphosphorylation is followed by a slower formation of high molecular weight tau oligomers that are stable to detergent extraction and gel filtration. TRT displays proteolytic processing with multiple cleavage products that are not observed for the monomeric version of tau. Cells expressing TRT show increased propensity for caspase activation and an activation of the unfolded protein response, suggesting that TRT expression initiates a cascade of pathological cellular responses that compromise cellular viability. Given multiple observations of similar post-translational processing of TRT in this model, compared to tau pathology in brains of patients with AD and other neurodegenerative tauopathies, we suggest that this model may be useful for delineating cell biology associated with tauopathy, as well as providing a model system for testing potential therapeutic agents.

Joel B Schachter is currently a Principal Scientist in the Movement Disorders and Translation Group at Merck. He joined Merck in 2009 as Director of Neurology and has held several positions there including Head of External Discovery and Preclinical Sciences for Neuroscience (XDPS) and Franchise Collaboration Lead for Neuroscience. In his role within XDPS, he was involved in building effective collaborations with external partners and in execution of preclinical drug discovery programs in the areas of Alzheimer's disease, Parkinson's disease, schizophrenia, and pain/migraine. As Franchise Collaboration Lead, he developed collaborative basic research efforts with academic partners. Prior to his work at Merck, he has spent 12 years at Pfizer as a Member of the Molecular Sciences Department and the Neurology group where he led project teams for several Alzheimer’s Disease-related drug discovery programs including GSK3, gamma modulators, and tau new targets.

Email: [email protected]

image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version